Chinanews.com, January 11th. According to the National Medical Insurance Bureau, on January 11th, the centralized procurement of oral implant systems was opened in Sichuan, and the results of the proposed selection were produced.

Under the guidance and coordination of the National Medical Insurance Bureau, the Sichuan Provincial Medical Insurance Bureau took the lead in forming an inter-provincial procurement alliance for oral implant systems, and all provinces across the country actively participated.

The average selected price of the products to be selected has dropped to more than 900 yuan, an average drop of 55% compared with the median purchase price before centralized procurement.

This centralized procurement gathers the demand of nearly 18,000 medical institutions across the country, reaching 2.87 million sets of implant systems, accounting for about 72% of the annual number of implants in China (4 million pieces), and is expected to save about 4 billion yuan in patient costs every year .

  A total of 55 companies participated in this centralized procurement, of which 39 companies were to be selected, with a selection rate of 71%.

The selected enterprises include not only some well-known international enterprises, but also domestic enterprises such as Weihai Weigao and Changzhou Bioconte.

Straumann, Dentsply, and Nuobaoke implant systems, which had relatively high prices before centralized procurement, dropped from the original purchase median price of 5,000 yuan to about 1,850 yuan. The median purchase price dropped from about 1,500 yuan to about 770 yuan, and the selected products were abundant, which achieved a good match with clinical needs; two kinds of implants with better performance and higher clinical acceptance were included, grade 4 pure titanium and titanium alloy. And it covers other consumable parts of oral implants, which can meet most clinical needs.

14,000 private medical institutions actively participated in this centralized purchase, accounting for 80% of the total number of medical institutions.

The extensive participation of private medical institutions will greatly facilitate the masses to enjoy affordable dental implant services.

  In the next step, the medical insurance department will do a good job in preparing for the implementation of the results of the centralized procurement and selection. In the near future, it will also carry out bidding for the crown consumables used in the dental implant process, and simultaneously implement the whole process of dental implant medical service price regulation, so that The three main types of cost components of dental implant services have declined simultaneously.

Through the coordinated efforts of a number of measures, it is expected that from late March to mid-April 2023, the results of comprehensive management of dental implant costs will be implemented, and patients will fully enjoy the reduced price of dental implant services.

(China New Finance and Economics)